50 results on '"Spagnoli, Giulio"'
Search Results
2. Maintenance of Primary Human Colorectal Cancer Microenvironment Using a Perfusion Bioreactor‐Based 3D Culture System
3. T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance
4. CD40 ligand-expressing recombinant vaccinia virus promotes the generation of CD8+ central memory T cells
5. Anti-Inflammatory/Tissue Repair Macrophages Enhance the Cartilage-Forming Capacity of Human Bone Marrow-Derived Mesenchymal Stromal Cells
6. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer
7. Mesenchymal stromal cells induce epithelial‐to‐mesenchymal transition in human colorectal cancer cells through the expression of surface‐bound TGF‐β
8. MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas
9. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope
10. Expression of cancer‐testis antigens MAGE‐A4 and MAGE‐C1 in oral squamous cell carcinoma
11. Paradoxical effects of T-cadherin on squamous cell carcinoma: up- and down-regulation increase xenograft growth by distinct mechanisms
12. MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies
13. Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells
14. Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma
15. High expression of cancer testis antigens MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, and gage in advanced squamous cell carcinoma of the larynx
16. Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer
17. A HCMV pp65 polypeptide promotes the expansion of CD4 + and CD8 + T cells across a wide range of HLA specificities
18. Cancer testis antigen expression in gastrointestinal stromal tumors: New markers for early recurrence
19. Use of multicellular tumor spheroids to dissect endothelial cell-tumor cell interactions: A role for T-cadherin in tumor angiogenesis
20. Permeability of Phospholipid Vesicles to the Tumor Antigen Epitope gp100280–288
21. Differential effects of the tryptophan metabolite3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines
22. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue
23. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer
24. NY‐ESO‐1/LAGE‐1 coexpression with MAGE‐A cancer/testis antigens: A tissue microarray study
25. Selective responsiveness to common gamma chain cytokines in peripheral blood‐derived cytotoxic T lymphocytes induced by Melan‐A/MART‐127–35targeted active specific immunotherapy
26. Three-dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study
27. The ester‐bonded palmitoyl side chains of Pam3CysSerLys4 lipopeptide account for its powerful adjuvanticity to HLA class I‐restricted CD8+ T lymphocytes
28. Cancer-testis antigen expression in uterine malignancies with an emphasis on carcinosarcomas and papillary serous carcinomas
29. Prognostic relevance of MAGE‐A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: A tissue microarray study
30. MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors
31. Monoclonal antibody 57B stains tumor tissues that express geneMAGE-A4
32. Anti-MAGE-3 antibody 57b and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family
33. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generatedin vitro from CD34+ hematopoietic progenitor cells
34. FLT3 ligand gene expression and protein production in human colorectal cancer cell lines and clinical tumor specimens
35. Naturally processed and concealed HLA-A2.1-restricted epitopes from tumor-associated antigen tyrosinase-related protein-2
36. GM-CSF gene expression and protein production in human colorectal cancer cell lines and clinical tumor specimens
37. Three-step tumor targetingvia biotin–avidin interaction as a versatile system to elicit T cell-mediated, non-MHC-restricted cytotoxic activity against neoplastic cells
38. C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity
39. High expression of MAGE-3 protein in squamous-cell lung carcinoma
40. Generation of tumoricidal cytotoxic T lymphocytes from healthy donors afterin vitro stimulation with a replication-incompetent vaccinia virus encoding MART-1/Melan-A 27-35 epitope
41. Cytotoxic T-lymphocyte responses against mutated p21 ras peptides: An analysis of specific T-cell-receptor gene usage
42. Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells
43. Peptide-specific ctl in tumor-infiltrating lymphocytes from metastatic melanomas expressing mart-1/melan-a, gp100 and tyrosinase genes: A study in an unselected group of hla-a2.1-positive patients
44. Bispecific monoclonal antibody anti‐CD3 X anti‐tenascin: An immunotherapeutic agent for human glioma
45. MAGE-1 gene product is a cytoplasmic protein
46. T‐helper‐ and accessory‐cell‐independent cytotoxic responses to human tumor cells transfected with A B7 retroviral vector
47. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes
48. Exogenous glutamine requirement is confined to late events of T cell activation
49. Expression of the human Vβ8 gene product preferentially correlates with class II major histocompatibility complex restriction specificity
50. Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.